A detailed history of Pasadena Private Wealth, LLC transactions in Amgen Inc stock. As of the latest transaction made, Pasadena Private Wealth, LLC holds 3,319 shares of AMGN stock, worth $874,158. This represents 0.24% of its overall portfolio holdings.

Number of Shares
3,319
Previous 1,909 73.86%
Holding current value
$874,158
Previous $596,000 79.36%
% of portfolio
0.24%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$309.38 - $337.38 $436,225 - $475,705
1,410 Added 73.86%
3,319 $1.07 Million
Q2 2024

Jul 19, 2024

SELL
$262.75 - $319.31 $249,875 - $303,663
-951 Reduced 33.25%
1,909 $596,000
Q1 2024

Apr 15, 2024

BUY
$268.87 - $324.56 $170,732 - $206,095
635 Added 28.54%
2,860 $813,000
Q3 2023

Oct 10, 2023

SELL
$218.65 - $271.46 $87,460 - $108,583
-400 Reduced 15.24%
2,225 $597,000
Q2 2023

Jul 11, 2023

BUY
$214.27 - $253.37 $562,458 - $665,096
2,625 New
2,625 $582,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pasadena Private Wealth, LLC Portfolio

Follow Pasadena Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pasadena Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pasadena Private Wealth, LLC with notifications on news.